Johns Hopkins spin-out GreyBug eyes up $1.74m in latest venture round.
GreyBug, a John Hopkins spin-out focused on eye diseases, has raised $1.74m in a series A2 round.
The round was co-led by new investor Hatteras Venture Partners and existing backer Maryland Venture Fund, and adds to a series A round held in 2013 for $1.5m. This is in addition to four Small Business Innovation Research grant awards the company has secured in the past year, totalling $650,000. As part of the A2 round, Christy Shaffer of Hatteras Venture Partners has…
